Tag: licensing
-
FDA Clears Algorithm-Assisted Cancer Diagnosis
The U.S. Food and Drug Administration cleared for marketing a diagnostics system aided by machine learning algorithms to help radiologists detect breast cancer.
-
Exosuit Shown to Improve Walking for Stroke Patients
A robotic device built and worn like clothing helps improve lower-limb walking performance for a group of people partially paralyzed with stroke.
-
Lilly Licensing Autoimmune Therapy in $400M Deal
Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system.
-
Biotech Licensing Viral T-Cell Immunotherapies
A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine.
-
Broad Institute in Crispr Licensing Program
One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology.
-
Chip Device Quickly Detects Sepsis in Blood
An engineering team designed a lab-on-a-chip device that in tests with hospital patients shows it can find signs of sepsis in a drop of blood in about 30 minutes.
-
Immune Disease Start-Up Raises $28M in Early Funds
A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing.
-
Exosuit Prototype Unveiled for Stroke Survivors
An assistive device with sensors and motors designed to help people with stroke and other muscle disorders walk more normally was demonstrated on 16 June.
-
Engineered Immune Cells to be Explored for Solid Tumors
A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers.
-
Univ. Spin-Off Discovering New Antibiotics
A new enterprise founded by three microbiologists at Harvard Medical School is licensing the founders’ research to find treatments for antibiotic-resistant bacteria.